Acadia Healthcare price target lowered to $40 from $44.50 at BofA

BofA analyst Joanna Gajuk lowered the firm’s price target on Acadia Healthcare (ACHC) to $40 from $44.50 and keeps a Buy rating on the shares. The firm says that on top of the “disappointing” guidance and lowered long-term growth outlook, Acadia shares were impacted by headlines that the House Republicans are now considering changes to the provider taxes. However, the risks appear to be more than priced in at current share levels, the analyst tells investors in a research note. BofA expects the healthcare facility stocks to be volatile given the continued headlines around potential reforms.